Hammerson in agreed bid for intu – The boards of Hammerson and Intu Properties have announced that they have reached agreement on the terms of a recommended all-share offer by Hammerson to acquire the entire issued and to be issued share capital of Intu. Intu shareholders will get 0.475 Hammerson shares for every Intu share that they […]
Custodian REIT sells Chepstow industrial estate – Custodian REIT has announced the disposal of a property from its portfolio. The company has sold a 82,081 sq ft multi-let industrial estate in Chepstow for GBP4.63 million, circa GBP0.9 million (25%) ahead of valuation and representing a net initial yield on sale price of 6.75%. The property was […]
Standard Life Equity Income boosted by asset manager stakes – Standard Life Equity Income has published results for the year to 30 September 2017. The Net Asset Value total return for the year was 14.7%, which compares with 11.9% from the All-Share Index. The discount narrowed slightly from 4.4% to 4.0%. This resulted in a share price […]
Majedie underperforms as absolute return investment loses money – Majedie says that, in the year ended 30 September 2017 the NAV (net asset value with debt at par) rose by 10.4% on a total return basis whilst the share price rose by 13.0%, also on a total return basis. The Board is recommending a total […]
Investment Trust Insider on ScotGems James Carthew: ScotGems’ soft start needs explanation It has been a busy year for new issues and we still might see a few more make it over the finish line before Christmas. Although property in various forms has been popular, we have also witnessed a few equity trust launches get […]
JPMorgan Asian’s dividend policy pays off – JPMorgan Asian reports that, in the year to 30th September 2017 the return on net assets was +21.5%, representing an outperformance of 2.7 percentage points over the benchmark, the MSCI AC Asia ex Japan Index, which returned +18.8% in sterling terms. The return to shareholders was +29.8%, reflecting a […]
BioPharma secures second deal for up to $200m – BioPharma Credit PLC has announced that it and BioPharma Credit Investments IV, S.àr.L., entered into a definitive term loan agreement for up to US$200 million with Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX), a fully integrated biopharmaceutical company with a current market capitalisation of approximately US$1.0bn. Lexicon markets XERMELO® (teloristat […]
BlackRock Frontiers premium persists despite share issues – BlackRock Frontiers Income reports that, during the year to 30 September 2017, the NAV increased by 21.5%, compared with the benchmark, the MSCI Frontier Markets Index, which rose by 25.5%. The MSCI Emerging Markets Index rose by 22.5% over the same period. (All performance figures are in US […]
Ground Rents Income ignoring discount problem? – In its results announcement this morning, the chairman of Ground Rents Income managed to make no mention of either the fund’s share price return for the year or its discount. For the record, the fund is trading at a discount of 10.4% to the net asset value at […]
Standard Life Private Equity benefits from narrowing discount – over the year to the end of September 2017, Standard Life Private Equity Trust’s net asset value produced a total return of 14.9% and its share price delivered a total return of 31.9%. The MSCI Europe Index returned 19.1% over the same period. As at the […]
